Tag: Inflammatory bowel diseases

AzurRx BioPharma acquires US biotech company First Wave Bio for $229m

businessnewstoday- September 14, 2021 0

AzurRx BioPharma has signed a stock and cash deal worth $229 million to acquire Florida-based clinical-stage biotech company First Wave Bio. The consideration includes payments ... Read More

Protagonist Therapeutics raises $22m equity financing from BVF Partners

pharmanewsdaily- August 6, 2018 0

Protagonist Therapeutics, a US biopharma company, focused on discovering and development of novel peptide-based drugs for patients with significant unmet medical needs, has raised a ... Read More